HLA-B*15 predicts survival in Egyptian patients with COVID-19.

Saved in:
Bibliographic Details
Title: HLA-B*15 predicts survival in Egyptian patients with COVID-19.
Authors: Abdelhafiz AS; Department of Clinical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt. Electronic address: ahmed.samir@nci.cu.edu.eg., Ali A; Department of Pulmonary Medicine, Abbassia Chest Hospital, MOH, Cairo, Egypt., Fouda MA; Department of Clinical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt., Sayed DM; Department of Clinical Pathology, South Egypt Cancer Institute, Assiut University, Assiut, Egypt., Kamel MM; Department of Clinical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt., Kamal LM; Department of Clinical and Chemical Pathology, Elsahel Teaching Hospital, MOH, Cairo, Egypt., Khalil MA; Department of Tropical Medicine and Infectious Disease, Imbaba Fever Hospital, MOH, Cairo, Egypt., Bakry RM; Department of Clinical Pathology, South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
Source: Human immunology [Hum Immunol] 2022 Jan; Vol. 83 (1), pp. 10-16. Date of Electronic Publication: 2021 Sep 27.
Publication Type: Comparative Study; Journal Article
Journal Info: Publisher: Elsevier/North-Holland Country of Publication: United States NLM ID: 8010936 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1166 (Electronic) Linking ISSN: 01988859 NLM ISO Abbreviation: Hum Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-1166
DOI:10.1016/j.humimm.2021.09.007